PPP1R11P2

Across TCGA pan-cancer cohorts, PPP1R11P2 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of PPP1R11P2’s most consistent transcriptional readouts.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where PPP1R11P2 RNA is repressed in tumor relative to normal tissue. In most cancer types PPP1R11P2 is over-expressed in tumor, although a few such as PAAD show the opposite, repressed pattern.

PAAD, COAD, and LUSC are the cancer types where PPP1R11P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in PPP1R11P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PAAD	Female	All	−0.329	.008	2	view →
COAD	All	All	+0.056	.038	1	view →
LUSC	Male	All	+0.042	.049	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

PPP1R11P2–PAAD

Open the PAAD breakdown →